相关实验视频

Updated: Jan 14, 2026

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
08:06

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Published on: November 27, 2019

9.5K

在2型糖尿病患者中进行两种间歇性禁食方法的随机并行干预试验的推理和方案

Felicia L Steger1, Joseph E Donnelly2, Robert N Montgomery3

  • 1Division of Endocrinology, Diabetes, and Clinical Pharmacology and KU Diabetes Institute; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA; Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA; Kansas Center for Metabolism and Obesity Research, Kansas City, KS, USA.

Contemporary clinical trials
|October 24, 2025
PubMed
概括

本研究将间歇性能量限制 (IER) 和时间限制的饮食 (TRE) 进行比较,用于2型糖尿病 (T2D) 管理. 结果将为超重或肥胖的T2D患者提供个性化的营养策略.

关键词:
血糖控制 血糖控制 血糖控制断断续续的禁食是一种禁食.肥胖问题 肥胖问题2 型糖尿病 2 型糖尿病减肥的方法 减肥的方法 减肥的方法

更多相关视频

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.6K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

13.0K

相关概念视频

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
861
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
677